HEALTHPEAK PROPERTIES, INC.

Insider Trading Arrangements

During the three months ended September 30, 2026, none of our directors or Section 16 officers adopted, modified, or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement.

Delayed Draw Term Loan

On October 28, 2026 (the “Closing Date”), the Company, along with Healthpeak OP, DOC DR Holdco, LLC, DOC DR OP Sub and the lenders party thereto and Bank of America, N.A., as administrative agent, executed an amendment to the Term Loan Agreement (the “Amendment”).

Pursuant to the Amendment, Healthpeak OP obtained senior unsecured delayed draw term loan commitments in an aggregate principal amount of $500 million (the “Incremental DDTL Facility”). The Incremental DDTL Facility is available to be drawn through July 2027 and has a stated maturity of four years. Loans outstanding under the Incremental DDTL Facility bear interest at an annual rate equal to (a) the applicable margin, plus (b) at Healthpeak OP’s option, (x) the base rate, (y) a forward-looking term rate based on the secured overnight financing rate as administered by the Federal Reserve Bank of New York (“Term SOFR”) or (z) the daily secured overnight financing rate as administered by the Federal Reserve Bank of New York (“Daily SOFR”), subject to a floor of, in the case of base rate, 1.00% and in the case of Term SOFR and Daily SOFR, 0.00%. The applicable margin under the Incremental DDTL Facility ranges from 0.00% to 0.55% for base rate loans and 0.70% to 1.55% for Term SOFR or Daily SOFR loans, in each case, based on the non-credit enhanced, senior unsecured long-term debt ratings of Healthpeak OP (“Debt Ratings”). Based on Healthpeak OP’s current Debt Ratings, the applicable margin is initially 0.00% for base rate loans and 0.80% for Term SOFR and Daily SOFR loans. The Incremental DDTL Facility is guaranteed by the Company, DOC DR Holdco and DOC DR OP Sub and is subject to customary affirmative and negative covenants.

Additionally, the maximum aggregate borrowing capacity under the Term Loan Agreement was increased from $2.0 billion to $2.75 billion (the “Incremental Increase”). As of the Closing Date after giving effect to the Amendment and including the available commitments under the Incremental DDTL Facility, unused borrowing capacity under the Healthpeak Term Loan Credit Agreement is equal to $1.5 billion.

The foregoing summary of the Amendment is qualified in its entirety by reference to the full text of the Amendment, which is filed herewith as Exhibit 10.1 and is incorporated by reference herein.